(Q38808593)

6 September 2017

Sexual dimorphism in cancer. (English)

1 reference

6 September 2017

1 reference

Andrea Clocchiatti

1

1 reference

6 September 2017

Elisa Cora

series ordinal

2

1 reference

6 September 2017

Yosra Zhang

series ordinal

3

1 reference

6 September 2017

G Paolo Dotto

series ordinal

4

1 reference

6 September 2017

language of work or name

English

0 references

publication date

15 April 2016

1 reference

6 September 2017

Nature Reviews Cancer

1 reference

6 September 2017

16

1 reference

6 September 2017

5

1 reference

6 September 2017

330-339

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc.2016.30

6 September 2017

0 references

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Global cancer statistics, 2012

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Thyroid cancer gender disparity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex differences in lung cancer survival: do tumors behave differently in elderly women?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gender differences in cancer susceptibility: an inadequately addressed issue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gonadotropin signalling in epithelial ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Correlation between serum prolactin levels and hepatocellular tumorigenesis induced by 3'-methyl-4-dimethylaminoazobenzene in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sexual dimorphism in environmental epigenetic programming.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Growth hormone and cancer: GH production and action in glioma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The androgen receptor in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Brain feminization requires active repression of masculinization via DNA methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

An oestrogen-receptor-α-bound human chromatin interactome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Human genomics. The human transcriptome across tissues and individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Progesterone signalling in breast cancer: a neglected hormone coming into the limelight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen plus progestin and colorectal cancer incidence and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Regulation of postnatal lung development and homeostasis by estrogen receptor beta.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Role of estrogen receptor beta in colonic epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Androgen receptor-mediated inhibition of cutaneous wound healing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Effects of steroid hormones on neurogenesis in the hippocampus of the adult female rodent during the estrous cycle, pregnancy, lactation and aging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Dyskeratosis congenita: its link to telomerase and aplastic anaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Telomere maintenance and human bone marrow failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gender aspects in chronic myeloid leukemia: long-term results from randomized studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Fibroblast heterogeneity in the cancer wound

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Stromal estrogen receptor-α promotes tumor growth by normalizing an increased angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Treating prostate cancer: a rationale for targeting local oestrogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

A sex-specific role for androgens in angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Multifocal epithelial tumors and field cancerization: stroma as a primary determinant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen Receptor-Alpha Promotes Alternative Macrophage Activation during Cutaneous Repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The X-files in immunity: sex-based differences predispose immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex differences in autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gender bias in autoimmunity is influenced by microbiota.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cancer and the microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Influence of sex on toxicity and treatment outcome in small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The X chromosome and immune associated genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Overexpression of X-linked genes in T cells from women with lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptors and the metabolic network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cachexia in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

An overview of sarcopenia: facts and numbers on prevalence and clinical impact

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Male hypogonadism associated with advanced cancer: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Foxa1 and Foxa2 regulate bile duct development in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Suppression by oestrogen of hepatocellular tumourigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex-differentiated deoxycholic acid promotion of rat liver carcinogenesis is under pituitary control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex and the liver - a journey through five decades

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The role of STAT proteins in growth hormone signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Hepatitis B and hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Oestrogen receptor-beta expression in melanocytic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Therapeutic significance of estrogen receptor β agonists in gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptor-beta affects the prognosis of human malignant mesothelioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

ATRX directs binding of PRC2 to Xist RNA and Polycomb targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Xist RNA is a potent suppressor of hematologic cancer in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Human UTY(KDM6C) Is a Male-specific N -Methyl Lysyl Demethylase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

PHF6 mutations in T-cell acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Medulloblastomics: the end of the beginning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Novel mutations target distinct subgroups of medulloblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Foxp3 expression in human cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

FOXP3-miR-146-NF-κB Axis and Therapy for Precancerous Lesions in Prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

FOXO1 regulates expression of a microRNA cluster on X chromosome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Aneuploidy of chromosome Y in prostate tumors and seminal vesicles: a possible sign of aging rather than an indicator of carcinogenesis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Sex chromosome alterations associate with tumor progression in sporadic colorectal carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Karyotypic characterization of urinary bladder transitional cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Mutagenesis. Smoking is associated with mosaic loss of chromosome Y.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Y chromosome structural and functional changes in human malignant diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The male-specific factor Sry harbors an oncogenic function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

SRY interacts with and negatively regulates androgen receptor transcriptional activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Gonadoblastoma locus and the TSPY gene on the human Y chromosome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Expression analysis of thirty one Y chromosome genes in human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Morphogens, morphostats, microarchitecture and malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

A Big Bang model of human colorectal tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Precancer: sequentially acquired or predetermined?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Perspective: Finding cancer's first principles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Cancer as an evolutionary and ecological process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

The future of immune checkpoint therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Why women live longer than men: sex differences in longevity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

31 March 2020

Estrogens and aging skin

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Drug insight: role of the androgen receptor in the development and progression of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Epigenetic Therapeutics: A New Weapon in the War Against Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.30

Roles of the Y chromosome genes in human cancers

31 March 2020

1 reference

12 December 2020

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer

1 reference

12 December 2020

Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines

1 reference

12 December 2020

Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

1 reference

12 December 2020

Prolactin in breast and prostate cancer: molecular and genetic perspectives.

1 reference

12 December 2020

Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation

1 reference

12 December 2020

Andropause. Testosterone replacement therapy for aging men

1 reference

12 December 2020

The Impact of Gonadal Steroid Hormone Action on Growth Hormone Secretion During Childhood and Adolescence*

1 reference

12 December 2020

A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2

1 reference

12 December 2020

Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC.2016.30

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference